Postoperative DAV-IFN-β therapy does not improve survival rates of stage II and stage III melanoma patients significantly

T. Matsumoto, K. Yokota, M. Sawada, A. Sakakibara, S. Shibata, S. Yasue, Y. Tomita, H. Yatsuya, M. Akiyama

Research output: Contribution to journalArticlepeer-review

13 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Postoperative DAV-IFN-β therapy does not improve survival rates of stage II and stage III melanoma patients significantly'. Together they form a unique fingerprint.

Medicine & Life Sciences